Techcyte Analysis: $182K Raised
What is Techcyte?
AI platform for anatomic and clinical pathology
Location
Orem, United States
Employees
51-200
Founded
2013
Latest Funding Round Size
Series A
Parent Company Website
Public Company Status
Private
Recent Venture Round Amount
$21,000,000
Product Features & Capabilities
- Techcyte Fusion digital pathology platform
- Fusion AP for anatomic pathology
- Fusion Frozen Section Suite for rapid diagnostics
- Techcyte SureView Cervical Cytology System
- Fusion Bacteriology Suite for microbiology analysis.
Use Cases
Streamline pathology workflows using AI-driven solutions; Enhance diagnostic accuracy in clinical laboratories; Improve efficiency in anatomic pathology processes; Facilitate rapid diagnosis with frozen section analysis; Automate cervical cytology assessments for better patient outcomes.
How much Techcyte raised
Series A - Series A
RecentOther Considerations
CE-IVDD marked in Europe; Collaborations with Mayo Clinic and BD; Founded in 2013, focusing on digital diagnostics.
Find more companies like Techcyte
See something that needs updating? Suggest edits to this profile.
